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When is it acceptable to allow a terminal patient to die? Pharmacy students' 
views from a London University. 
Introduction 
Accompanied suicide is illegal in the UK under the terms of the Suicide Act (1961). If found to 
be assisting a family member or loved one to end their life, such person(s) may be punished by 
up to 14 years imprisonment1,2. If a doctor is found to be involved in deliberately ending a 
patient’s life then they could be charged with manslaughter, or even murder – the maximum 
penalty of which is life imprisonment1.  
Although it is not yet legal in the UK, there are many ongoing debates regarding whether it 
should be legalised in the near future. Organisations such as Dignity in Dying regularly 
campaign to allow the option of assisted dying for ‘terminally ill, mentally competent adults3’. 
Recently the Royal College of Physicians have dropped their opposition of accompanied 
suicide, now adopting a neutral stance4,5, and the increase in coverage has prompted both the 
Royal College of General Practitioners and the British Medical Association to survey their 
members on the topic. Both associations are currently opposed to a change in the law6,7. It was 
also mentioned in Parliament in July 2019, with more debates on the topic sure to follow in the 
near future. 
Currently, accompanied suicide is legal in 4 countries in Europe.  Switzerland, where DIGNITAS 
was founded; defined as an organisation with the ‘objective on ensuring a life and a death with 
dignity for its members.’8 DIGNITAS accepts terminally ill people from all over the world, with 
over ‘7100 members in 69 different countries’8, including the UK. The Netherlands legalised 
euthanasia in 2001 and practice with strict condition that patient’s suffering must be 
‘unbearable and without prospect of improvement (hopeless)’9, although services in The 
Netherlands are not strictly patients with terminal illnesses. There have been a few cases 
involving patients with severe mental health issues (such as depression) and dementia. 
Luxembourg, who passed a law that came into action in 2009, states that patients with either 
an incurable medical condition leading to unbearable physical or mental suffering, or making 
end-of-life arrangements may be able to file a request for euthanasia or assisted suicide10. 
Finally, Belgium amended their law on euthanasia in 2014 to enable euthanasia of a child, 
making them the only country in the world to legalise child euthanasia where the child must 
actively request it and have the capacity to understand the implications11. It is also legal in 
Victoria, Australia, Canada, Colombia and 9 states in the US (with Maine becoming the tenth in 
2020). 
If the UK were to legalise accompanied suicide, then pharmacists will have a role in supplying 
and dispensing the medication to deliberately end a patient’s life. Therefore, there should be 
adequate teaching on the topic to pharmacy students to ensure they have the knowledge to 
answer queries and handle dilemmas they may face with a new law. Moreover, conversations 
and teaching in pharmacy will enable pharmacists (and students) to confidently voice their 
opinions on accompanied suicide and their reasoning.  
Defining Euthanasia 
The definition of euthanasia can be easily confused as there are varying opinions and many 
different terms to describe specific processes. Terms accepted and defined by the non-profit 
organisation DIGNITAS include: 
• ‘Accompanied suicide – compromising elements of assistance with a self-determined 
end of life and accompaniment of dying patients12.’ 
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• ‘Direct active euthanasia on express request (voluntary euthanasia) – the person 
wishing to end his/her own life requests and permits a third person to put an end to 
his/her life12.’ 
An additional term, suggested by the UK campaign Dignity in Dying is: 
• Assisted dying – ‘a term used to describe when a terminally ill, mentally competent 
adult, making the choice of their own free will and after meeting strict legal 
safeguards, takes prescribed medication which will end their life.’3,13  
Confusion on the definitions alone shows that the UK does not have advanced knowledge on 
accompanied suicide (and likewise terminology); suggesting pharmacists in the UK will also be 
lacking an understanding of the topic. 
Accompanied Suicide and Related Topics in Pharmacy Education 
Any potential confusion surrounding accompanied suicide, and related topics such as end-of-
life and palliative care, in the pharmacy community may be partly explained due to potential 
lack of education and understanding of terminology – if the students are less educated on 
these topics, they could be less likely to feel comfortable with playing a part in the process. 
Very few studies have been completed with pharmacists and/or pharmacy students on their 
knowledge surrounding accompanied suicide; and whilst there are more studies on end-of-life 
and palliative care, those results have been lacklustre. 
End-of-Life and Palliative Care Education in US Pharmacy Schools14 
 
Dickinson’s 2012 study on the education of end-of-life and palliative care in pharmacy schools 
in the US found that education on this topic is deficient within pharmacy curricula. The study 
involved a fixed-choice questionnaire sent to 125 pharmacy schools in the US. Results found 
only ‘10% of pharmacy schools offered a ‘‘separate course’’ on dying and death’14 and ‘18% 
said that death and dying is ‘‘not taught formally’’’14. Dickinson also found there to only be 
‘54% US pharmacy schools covering euthanasia as a topic’14, showing that even in a country 
where euthanasia is legal in 10 states (from 2020), the education given to pharmacy students 
is very basic (if educated at all). This study identified a gap in pharmacy education on 
accompanied suicide, and no other similar studies have been conducted elsewhere. 
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Aim 
The primary aim of this study was to inform current education of final year MPharm (Master of 
Pharmacy) students and explore their views on accompanied suicide and the influencers that 
may affect one’s views. Both patient and participant factors were explored to determine any 
influence over their views, including their knowledge on accompanied suicide. 
Methodology 
Overview 
This project was an anonymous cross-sectional cohort study consisting of an online survey to 
explore the perceptions of final year Kingston University (KU) pharmacy students. The survey 
was open from January-March 2019 and was available via SurveyMonkey. Elements from other 
surveys used in previous studies (referenced above) were incorporated into this survey to 
ensure the questions were in an appropriate and concise manner. 
There were found to be 139 final year students at KU, therefore (assuming the confidence 
levels were 95% and the intervals 5%) the minimum sample size required for this study to be 
significant to the population was 103, using the SurveyMonkey sample size calculator. Due to 
the sensitive nature of the study, it was imperative to seek ethical approval from the SEC 
faculty committee of KU - this was granted January 2019.  
Survey Outline 
The survey was separated into the following three sections: 
Section A 
This section involved asking the participants to choose the correct definition of ‘voluntary 
euthanasia’, ‘accompanied suicide’, and ‘assisted dying’ from the definitions listed, with the 
actual definitions of all 3 revealed using the official definitions by DIGNITAS and Dignity in 
Dying. Furthermore, there were 3 questions asking whether they thought the above terms 
were legal in the UK, with their answer prompting information to be given on the law of 
accompanied suicide in the UK.  
The aim of this section was to determine how educated the participants were on accompanied 
suicide and likewise terms - something that could be addressed and taught in pharmacy 
cohorts in the future. 
Section B 
This section consisted of four real-life vignettes of patients with terminal illnesses who showed 
a desire to end their lives via accompanied suicide. These patients varied in their illnesses, 
gender, and their age. As their illnesses varied, their mental capacity and ability to self-
administer medication may have also been questioned by the participants. Nevertheless, it 
was suggested that each patient’s level of pain would not have improved from that point 
onwards, they were terminally ill and were therefore not expected to survive the next 12 
months, and that they were not being coerced or blackmailed in any way to end their life. 
Moreover, a trigger warning was displayed before the cases were shown to the participant; 
warning them that the next topics involved terminal illnesses and patients requesting 
accompanied suicide, so if the topic was too sensitive, they could back out before being 
exposed to it. Had the participant chosen to proceed, a short abstract about the patient case 
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was shown before receiving a series of statements to answer. The full case studies can be 
found in Appendix A. 
• Case study 1 involved a 29-year-old female with terminal brain cancer, with full mental 
capacity and the ability to self-administer the lethal medication.  
• Case study 2 consisted of a 67-year-old male with motor neurone disease (MND) who 
had full mental capacity, however, may not be able to self-administer the lethal 
medication.  
• Case study 3 involved a 60-year-old male with terminal liver cancer who had the ability 
to self-administer the lethal medication; however his mental capacity was 
deteriorating (after requesting accompanied suicide with full mental capacity). 
• Finally, case study 4 included a 14-year-old female with end-stage cystic fibrosis (CF). 
She had full mental capacity for a child of her age and was able to administer the lethal 
medication. 
The statements were Likert-scale styled, including the choices – strongly agree, agree, neither 
agree nor disagree, disagree, and not sure. An example of such statements given is: ‘I agree 
with the patient’s request to end their life via accompanied suicide’. Additional Likert-style 
statements were introduced to determine the reasoning behind the participant’s decision, 
ranging from a personal limitation (i.e. their own knowledge on the topic), to the patient in 
question (i.e. their age, gender, illness, mental capacity, etc.). To ensure validation of the 
answers, some of the questions were repeated in a similar manner. 
The reasoning behind these questions was to determine both the personal and professional 
opinions of the participants and to understand whether they would differ with each case 
presented to them in the previous section. This also determined personal or patient-specific 
factors that may influence the participant’s opinion.  
Section C 
This section included the demographics of the participants, such as their age, gender, their 
postal code (aka home-time address), ethnicity, and their religion. The latter of the 
demographics expanded if the participant answered that they identify with a religion; enabling 
them to develop on whether they felt that they actively follow their religion on a day-to-day 
basis. This then prompted a further question to ask how much of an influence they believe 
their religion could have had on their personal opinions expressed in section B. This could 
gauge a deeper insight into the personal beliefs/traits that may conflict with values of a 
healthcare professional, and how these could be discussed in the future. 
Furthermore, questions regarding the content of their MPharm course, and their past 
experience with a loved one were included to understand the previous exposure the 
participants may have had on the topic. 
Statistical analysis 
Data analysis consisted mostly of descriptive statistics using Statistical Package for the Social 
Sciences (SPSS) statistics, consisting of a range of tabulations and graphs with chi-squared 
testing to determine the level of significance.  
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Results 
N.B. any Likert scale results have combined ‘strongly agree’ with ‘agree’ responses, and ‘strongly 
disagree’ with ‘disagree’ responses. Data has been numbered in Likert scales, where 1 = agree, 2 = 
neither agree nor disagree, 3 = disagree, and 4 = not sure. P-values have been labelled as ‘Sig.’ 
The data collected yielded a total 111 responses of a possible 139 (80% response rate), with 25 
surveys left incomplete. This gave a completed response rate of 62%, though all responses 
were analysed. All tables and SPSS cross-tabulations are also displayed in the Appendices A-C. 
Demographics 
Of 111 responses, 58 were female and 24 were male (table 1). The remainder either preferred 
not to say or did not respond. As expected, 79% (n=68) respondents were between the ages of 
18-24 (61.3% of the unspecified responses are also included).  
The most frequent ethnicities were Asian (n=34), Black (n=17) and Arab (n=15). The home-time 
postal code of students was asked to determine their usual address when they are not at 
university. 53.2% (n=59) students asked were originally from London, with 11.6% (n=13) from 
Southern regions of the UK, 7.2% (n=8) from Northern regions (including Yorkshire and The 
Humber) and only 2.7% (n=3) respondents living internationally. 
Almost 70% (n=76) responses identified with a religion (46 of those describing themselves as 
Muslim). Of those 70% who said they were religious, just under 80% (n=63) also said they 
currently practice their religion (figure 1) and 58.2% (n=46) believed their religion to influence 
their opinions on accompanied suicide (figure 2). 
A complete table of demographics can be found in Appendix B (Table 1, Figure 1 and 2). 
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Knowledge of MPharm students 
Figure 3 participants' answers to each question regarding the definition of the terms given to them. The terms were 
'voluntary euthanasia', 'assisted dying' and 'accompanied suicide'. 
 
Figure 3 represents the percentage of correct and incorrect answers of each definition. 
Regarding the term ‘voluntary euthanasia’, only 21.6% (n=24) could correctly determine the 
matching definition. This value fell to 10.8% (n=12) when defining ‘assisted dying’ but rose to 
35.1% (n=39) when defining ‘accompanied suicide’.  
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Figure 4 percentage at which participants of the study said they agreed that their lack of knowledge influenced their 
opinions on accompanied suicide in each case study (excluding ‘unspecified’ results) 
Additional to the definition matching exercise presented to them in Section A, the participants 
were also asked if they believed their lack of knowledge to influence their views on 
accompanied suicide in each case study. Figure 4 shows the percentage of participants who 
agreed to this statement with regards to each case study. Almost 50% of participants in every 
case stated that their lack of knowledge did influence their opinions. 
Furthermore, participants were asked if they believed that they had been taught the aspects of 
accompanied suicide on their course, and if this had influenced their opinions. Most results 
found no link between the two. 
The Law 
Conversely, most participants (93.7%, n=104) were able to correctly identify that all three 
practices given to them were illegal in the UK (table 2). There were no incomplete responses in 
section A. 
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The Personal Views 
One of the main aims of this study was to determine the opinions of pharmacy students on 
accompanied suicide in relation to specific vignettes. The full tables can be found in Appendix 
C (Tables 3 and 4). 
 
Figure 5 participant's opinions on accompanied suicide with regards to each case study (excluding ‘unspecified’ 
results), where green = case 1, purple = case 2, orange = case 3, blue = case 4. 
Figure 5 demonstrates the views of participants on accompanied suicide as a bar graph (in 
percentage form). The graph shows a general opposition to accompanied suicide with all 4 
cases – the case with the largest opposition being case 4 (14-year-old female with end-stage 
CF) with 66.3% (n=57) of 86 responses. 
The Influential Factors 
N.B. Chi-square results are determined by two-by-two categorical data – in each of the results, only 
‘agree’ and ‘disagree’ responses were measured. All other responses were discounted. 
An additional main aim of this study is to determine the specific factors that may influence 
one’s views on accompanied suicide. Such factors can be broken down into two categories – 
patient and participant factors. 
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The Patient Factors 
The patient factors are specific to the case study, where the features of the patient themselves 
may influence the opinion of the participant: examples of the factors that were measured 
include:  
• Gender 
• Age 
• Terminal condition 
• Ability to self-administer medication 
• Current mental capacity 
Responses were culminated to determine the patient factor in each case that would have been 
most likely to influence participants’ opinions. 
The greatest influential patient factors of case study 1 (29-year-old female with metastatic 
brain cancer) were found to be the terminal disease the patient was suffering from (37.76%, 
n=37 of 98), with the least influential factor found to be the gender of the patient, at only 7.2% 
(n=7 of 97). 
Akin to case 1, case 2 (67-year-old male with MND) found the disease of the patient was found 
to be the greatest influence with 34.0% (n=32) of 94 responses agreeing this patient’s disease 
affected their view on the request. The gender of the patient was, again, found to be the least 
influential factor for the participants’ views – only 8.3% (n=8) of 96 responses agreed to this. 
Case study 3 (60-year-old male with terminal liver cancer) had a slight change to the top 
influential factors, with a new factor, specific to this patient, practically level with the disease 
of the patient – the mental capacity of this patient was found to influence 36.4% (n=32) of 88 
responses, and the disease influenced 37.1% (n=33) of 89 responses. The gender of the 
participant remained the least influential factor at 6.8% (n=6 of 88 responses).  
Lastly, case 4 (14-year-old female with end-stage CF) found a slight change in the results. As 
opposed to the previous cases, the most influential factor was found to be the age of the 
patient, with 44.2% (n=38) of 86 responses agreeing that her age affected their views. As with 
every other case, gender was found to be the least influential factor, with less than 7% (n=6) of 
86 responses claiming it to influence their opinion. 
The Participant Factors 
Alongside the theory that patient factors may influence a participant’s opinion, the 
participant’s factors themselves may equally have an impact. Such factors include: 
• Demographics  
o Gender 
o Age 
o Ethnicity 
o Postal Code 
o Religiosity 
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• Experience with terminal illness/accompanied suicide of a loved one in the past.  
Chi-square tests were conducted to deduce the factors that are linked with the participant’s 
view. All tables can be found in Appendix D (Tables 5-17). Of all demographics, the 
participants’ religion was the only factor to have a statistically significant influence on their 
opinions on accompanied suicide with a p-value of <0.05. 
Discussion 
To our knowledge, this is the first study to investigate the education and opinions of pharmacy 
students on accompanied suicide. 
General Opinions 
Most participants disagreed with the request for accompanied suicide with each case study, 
which contrasts to recent studies carried out by the campaign for Dignity in Dying and Porter 
and Warburton’s 2018 article on the evolution of the Royal College of Physicians’ (RCP) views 
on AS. Dignity in Dying found 84% of people in Great Britain ‘support a change in the law’15, 
and Porter and Warburton compared results results from 2006 and 2014 survey to discover 
the percentage of respondents answering a change in the legislation was not required had 
decreased from 73.2% (n=3741) to 62.5% (n=4179)16. The latest RCP survey (conducted in 
2019) found even fewer respondents believing the RCP should be against a change in 
legislation (43.4%, n= 2988), resulting in an overall no majority view, changing the RCP’s 
position to neutral5.  
There are also differences between this study and both the 2000 study by Hanlon et al 
involving British community pharmacists and Terkamo-Moisio et al’s 2016 paper on Finnish 
Nurses’ Attitudes towards Euthanasia. Hanlon et al’s paper found similar views to those found 
from the 2019 RCP survey on AS. The paper concluded of the 320 pharmacists questioned, 
‘70% pharmacists agreed that it was a patient’s right to choose to die, but the agreement 
reduced to 57% when asked about extending the right to choose to die to include the right to 
involve one’s physician’17 – still a majority in agreement in comparison to this study. Terkamo-
Moisio et al’s paper found 89.9% respondents (n=901) believing a person must have the right 
to decide on their own death, and 74.3% accepting euthanasia as part of the Finnish 
healthcare18. 
From the graph shown in figure 5, it is clear that case study 4 showed the greatest opposition 
towards the patient’s request, whereas case 2 gave the greatest support. The differing patient 
factors could have influenced the variation in these results, such as their age, gender, illness 
etc. 
Pharmacy Undergraduate Curriculum 
The level of understanding of accompanied suicide and similar terms were found to be very 
poor amongst the MPharm students of KU. Section A of the survey showed that overall; most 
definitions chosen for each term by the participants were incorrect. An average of 86 (77.5%) 
participants answered each of the questions regarding definition incorrectly, and only 2 (1.8%) 
participants were able to correctly identify all three definitions – clearly showing a lack of 
education on the topic.  A potential explanation for this may be due to various organisations 
defining terms differently, hence leading to confusion on the official definitions. 
On the contrary, the participants seemed substantially more knowledgeable on the laws of 
accompanied suicide in the UK. This contradicts with the notion that participants are 
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completely uneducated in accompanied suicide; however there is substantial evidence from 
this study to show the lack of knowledge in many other areas. Accompanied suicide has gained 
more awareness in the media, popular TV shows (such as Coronation Street), and cinematic 
movies (such as Me Before You) over recent years; potentially playing into the greater 
understanding of the laws associated. 
Since the study was limited only to students at KU, it cannot be definitively concluded that all 
other universities would develop similar results - further studies will need to be conducted 
involving other universities across the UK to prove this conclusion. Should results stand similar 
at other universities, this could trigger more teaching on accompanied suicide; with the aim of 
educating future pharmacists on the topic and the processes involved were it to be legalised in 
the future. KU is also a very ethnically diverse university, and whilst results were able to reflect 
London quite accurately, it was not reflective of the rest of the UK. 
The Patient Factors 
In order to understand any variance of participant opinions between each case study, it was 
important to recognise the patient factors in each case and compare it to the opinions of the 
participants. 
General Factors 
Most patient factors explored did not play a significant role in the participants’ opinions. 
Factors such as the gender and the ability to self-administer lethal medication showed no 
significance or influence.  
The disease of the patient, whilst being found as one of the main patient factors to influence 
the participants’ opinions, did not strongly point to any one specific disease. This may suggest 
confusion in pharmacy students with regards to certain diseases they may not be more 
exposed to (such as MND and CF). Case 3 also found the patient’s declining mental capacity as 
one of the most influential factors, however it cannot be concluded that this would be 
statistically significant as it was only measured in one patient case. 
The Patient’s Age 
It was decided to measure any connection between the patient’s age and the opinion of the 
participant since studies conducted seemingly suggested that the public are more opposed to 
childhood accompanied suicide in comparison with adults. 
Deak et al’s 2015 study on child euthanasia aimed to determine the factors involved in 
opposition to the topic – including participant factors such as their religion. A total of 213 
participants completed the questionnaire, with mostly Belgian participants (79%)19. A question 
asked the participants how much they agreed with the new laws on child euthanasia in 
Belgium, discovering 71.8% accepted child euthanasia (with 50% agreeing if the motive was ‘to 
end the severe suffering of seriously ill children’19). Though this value showed the participants 
were quite accepting of child euthanasia, it was discovered to be lower than the acceptance 
towards adult euthanasia (86%)20, found in a similar study conducted by the same authors20. 
Though many factors were measured to determine the reasoning behind the participants’ 
opinions in this study, one that was not included was their level of knowledge on euthanasia 
involved in children. It could be argued that since this was such a new legislation when the 
article was written, little could have been known about it among the participants, therefore 
their opinions may have been based more on the legislations they were already familiar with 
(i.e. adult euthanasia in Belgium). 
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The 2015 study resulted in the varied ages in this study, from 67 (case 2) to a mere 14-years-
old (case 4).The influence of age in cases 1-3 remained rather insignificant, however case 4 
found almost half of respondents stating the age of the patient to influence their opinions on 
her request to end her life. Considering the momentous opposition to case study 4’s request 
for accompanied suicide, it would make sense to assume the young age of the patient 
substantially influenced the MPharm students’ opinions on her request. More specifically, 
pharmacy students are more likely to disagree with a patient’s request to end their life via 
accompanied suicide if they were a child. 
If the UK were to ever legalise accompanied suicide in the future, the age of the patient should 
be taken into careful consideration. As problematic as the situation may be when involving a 
paediatric patient, it would be unacceptable to discriminate against a patient’s wishes purely 
due to their age. 
The Participant Factors 
General Factors 
As with the factors of the patient, the factors of the participant themselves could be found to 
play a significant role in their opinions. From the results found, it can be concluded that most 
of the participant factors measured did not have any statistically significant link to their 
opinions on each case study (gender, age, ethnicity, postal-code, past experience, and taught 
aspects). Some of these results may not, however, be accurate enough to draw a conclusion. 
For instance, as the majority of participants (61.3%, n=68 of 86) claimed to be between the 
ages of 18-24, there may not be a sufficient variety of older ages to confirm this conclusion. 
For more accurate results, further studies should be undertaken including older generations of 
participants who had studied pharmacy (such as newly qualified and experienced 
pharmacists).  
The Participant’s Religion 
Considering the widespread investigations into religiosity and ethical views, it was integral to 
include the participant’s religion as a measurable factor. Of all the participant factors, this was 
the only statistically significant link against their opinions - tables 6, 9, 12, and 15 all display 
each p-value as <0.05.This can therefore conclude that pharmacy students who identify with a 
religion are more likely to be opposed to accompanied suicide, supporting previous literature. 
Moreover, this verifies that a pharmacy student who actively practices their religion is 
significantly more likely to disagree with a patient’s request to end their life via accompanied 
suicide. 
Additional studies gave similar findings between religion and opinions towards AS. Hussain and 
White’s 2009 qualitative study on UK GP’s views on the practice of physician-assisted suicide 
(PAS) and their specific role revealed some GPs recognising their personal aspects influencing 
their views, such as ‘personal experience and religious teaching’21, although they had stated 
their religion had not made them opposed to PAS, it was instead the ‘concern regarding doing 
harm’21. Hanlon et al’s study, however, found a ‘significant association between those who 
declared a religious and/or ethnic background and a less favourable attitude to PAS17’. 
Terkamo-Moisio et al also compared their results with the religiosity of the respondents. 
Similarly to Hanlon et al’s conclusion, Terkamo-Moisio et al stated that ‘Nurses’ religiosity is 
widely recognised as a strong indicator of their attitudes towards euthanasia, correlating 
negatively with support for the practice’18. 
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Limitations 
A few limitations arose in this study that could be improved in future studies. Firstly, only final 
year KU students from 2019 were surveyed, therefore not representative of final year MPharm 
students in London without considering the views of those around the rest of the UK who may 
have opposing opinions. Especially since London is an area with diverse religious beliefs, the 
more rural areas of the UK could present with a very different outlook on the topic. 
As the study is limited to final year students, most participants will be between the ages of 20-
25 (barring a few mature students). This hence limits the results to a certain generation of 
people and does not well represent other generation’s views. Recent articles by Dignity in 
Dying4,15 and Royal College of Physicians5 suggest there has been a general increase in support 
towards accompanied suicide over the years, therefore there could be an even stronger 
opposition towards accompanied suicide with pharmacists who have been practicing for many 
years.  
Finally, the patients involved in each vignette all had terminal illnesses (in the sense that they 
were expected to die in the next 12 months). Although this will still pose many diverse 
opinions, this questionnaire did not deliberate any patients with life-limiting illnesses that may 
not necessarily be deemed ‘terminal’ at that stage in the person’s life. For instance, a patient 
diagnosed with rheumatoid arthritis who is in constant pain and is limited to doing certain 
everyday tasks, or a patient who has been newly diagnosed with a slowly deteriorating disease 
such as multiple sclerosis or dementia. These types of cases could pose an even more 
controversial and challenging decision as the patient could have a lot more of their life to live 
(even if the quality of their life is poor), which may affect the views of some people.  
Recommendations 
Considering the results obtained from this study, three following changes were recommended 
to improve the education of pharmacy students: 
1. Approved definitions of accompanied suicide and likewise terms – one specific, 
certified medical organisation should approve clear and concise definitions of 
accompanied suicide and similar terms associated with it. These definitions should 
then be the set definitions understood in the UK, therefore avoiding confusion of the 
terminology (as is the current situation). 
2. Including accompanied suicide in the pharmacy syllabus – this study concluded that 
future pharmacists in the UK are very uneducated on accompanied suicide; and since 
they will likely be exposed to patients with terminal illnesses at some stage in their 
careers, it would be logical to have some inclusion of accompanied suicide onto their 
syllabus. Whether accompanied suicide becomes legalised in the UK or not, this 
knowledge could be extremely beneficial in conversations with patients (or families of 
patients) who may ask questions revolving around end-of-life and accompanied 
suicide. 
3. Inclusion of lesser known terminal illnesses in the pharmacy syllabus – whilst 
pharmacy students seem to have a good understanding of well-known terminal 
diseases in the UK (such as cancer and heart failure), they are less educated on less 
common terminal illnesses (such as MND, CF, MS etc.) A better understanding into 
these diseases at their terminal stages may enable pharmacy students to more 
confidently conclude their opinions on accompanied suicide in specific illnesses. 
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Future Work 
As this study was the first of its kind to involve pharmacy students, the hope is for the 
awareness of accompanied suicide and the role of the pharmacist to extend further to the rest 
of the UK, triggering further studies of a similar nature to cement conclusions into the 
education and opinions of pharmacy students and pharmacists. There is a possibility that 
accompanied suicide (or any other similar practice) could become legal in the UK in the future, 
so as well as enabling future pharmacists to answer queries of patients/patient’s families with 
confidence, knowledge regarding accompanied suicide could become vital for ideal pharmacy 
practice. 
This study will also be repeated on oncology pharmacists in the UK in the near future to 
understand their views and education on the topic, and hopefully will be able to evolve into a 
study for international pharmacists to compare the results (in both countries where 
accompanied suicide (or similar terms) is and is not legal). 
Conclusion 
Conducting this study has revealed the true lack of knowledge future pharmacists have on 
accompanied suicide, which may enable additional teaching on the topic in the MPharm 
degree in the future. Moreover, the study has shown most final year Kingston MPharm 
students would disagree with a patient’s request to end their life via accompanied suicide 
(regardless of the patient’s situation). Nevertheless, there has been shown to be certain 
influential factors of the patient affecting the views of the MPharm students, such as their age, 
the terminal illness they are suffering from, and even their mental capacity – probably 
influencing the views of pharmacy students due to the ethically problematic aspect of each 
feature. Additionally, it has concluded that religious participants are much more likely to 
oppose accompanied suicide compared with those that do not practice a religion. 
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Appendix 
Appendix A – Case Studies: 
• Case 1 - A 29 year old female suffering from an aggressive malignant brain tumour wishes to 
end her life via accompanied suicide. In recent weeks she has been experiencing increasingly 
frequent and longer seizures, severe head and neck pain, and stroke-like symptoms. She is 
afraid of her brain tumour changing her behaviour and causing her pain during the last few 
months of her life so she has therefore requested accompanied suicide from her doctor. She 
has full mental capacity and she would also be able to self-administer the lethal medication. 
• Case 2 - A 67 year old male suffering from the effects of Motor Neurone Disease (MND) wishes 
to end his life via accompanied suicide. He fears becoming entombed in his own body and 
experiencing a traumatic, drawn-out death so he has therefore requested accompanied suicide 
from his doctor. He currently has full mental capacity to make this decision, however due to his 
condition, he may not be able to self-administer the lethal medication. 
• Case 3 - A 60 year old male with terminal liver cancer wishes to end his life via accompanied 
suicide. He has recently lost the use of his legs and is only able to crawl. He has also become 
very breathless, therefore he has requested accompanied suicide from his doctor. His mental 
capacity is declining and he is becoming increasingly confused, however he requested this 
decision when he had full mental capacity. He would be able to self-administer the lethal 
medication. 
• Case 4 - A 14 year old female in the end stages of cystic fibrosis (CF) wishes to end her life via 
accompanied suicide. She is tired of living with the terminal disease which causes recurrent 
infections and tissue damage. Her breathing has become increasingly difficult, therefore she 
has requested accompanied suicide from her doctor. She has full mental capacity for a child her 
age and is able to self-administer the lethal medication. 
 
Appendix B - Demographics 
Demographics Table: 
 
Count 
 (n = 111) Percentage (%) 
Gender Female 58 52.3 
Male 24 21.6 
Prefer Not to Say 4 3.6 
Other 0 0.0 
Unspecified 25 22.5 
Total 111 100.0 
Age 18-24 68 61.3 
25-34 13 11.7 
35-44 4 3.6 
45-54 1 0.9 
55-64 0 0.0 
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65+ 0 0.0 
Unspecified 25 22.5 
Total 111 100.0 
Ethnicity White 10 9.0 
Black 17 15.3 
Mixed 3 2.7 
Arab 15 13.5 
Asian 34 30.6 
Prefer Not to Say 4 3.6 
Other 3 2.7 
Unspecified 25 22.5 
Total 111 100.0 
Postal Code East 0 0.0 
East Midlands 1 0.9 
London 59 53.2 
North East 2 1.8 
North West 5 4.5 
Northern Ireland 0 0.0 
Scotland 0 0.0 
South East 8 7.2 
South West 5 4.5 
West 0 0.0 
West Midlands 2 1.8 
Yorkshire and The Humber 1 0.9 
International 3 2.7 
Unspecified 25 22.5 
Total 111 100.0 
Religion Christian 11 9.9 
Catholic 3 2.7 
Orthodox 2 1.8 
Jewish 1 0.9 
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Muslim 46 41.4 
Buddhist 2 1.8 
Hindu 6 5.4 
Sikh 3 2.7 
Atheist/Agnostic 3 2.7 
Nothing in Particular 4 3.6 
Prefer Not to Say 3 2.7 
Other 2 1.8 
Unspecified 25 22.5 
Total 111 100.0 
 Past Experience Yes 20 18.0 
No 39 35.1 
Unspecified/Skipped 52 46.8 
Total 111 100.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 demographics of the participants 
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Religion Pie Charts: 
 
 
 
 
 
 
Figure 1 are participants actively practicing their religion? 
Figure 2 do participants believe their religion influenced their opinions of accompanied suicide? 
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Appendix C – Frequency Tables: 
Section A: 
Law: 
 
 
 
 
 
 
 
 
 
 
 
Section B: 
Opinions: 
Opinions on Accompanied Suicide with each Case Study 
 Count (n = 111) Percent (%) 
Case Study 1 Agree 30 27.0 
Neither Agree nor Disagree 15 13.5 
Disagree 52 46.8 
Not Sure 2 1.8 
Unspecified 12 10.8 
Total 111 100.0 
Case Study 2 Agree  32 28.8 
Neither Agree nor Disagree 18 16.2 
Disagree 44 39.6 
Not Sure 2 1.8 
Unspecified 15 13.5 
Total 111 100.0 
Case Study 3 Agree 25 22.5 
Neither Agree nor Disagree 16 14.4 
Is it legal in the UK? 
 Count (n = 111) Percent (%) 
Voluntary Euthanasia Yes 5 4.5% 
No 106 95.5% 
Assisted Dying Yes 12 10.8% 
No 99 89.2% 
Accompanied Suicide Yes 5 4.5% 
No 106 95.5% 
Table 2 the laws on accompanied suicide and associated terms in the UK 
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Disagree 43 38.7 
Not Sure 4 3.6 
Unspecified 23 20.7 
Total 111 100.0 
Case Study 4 Agree 16 14.4 
Neither Agree nor Disagree 9 8.1 
Disagree 57 51.4 
Not Sure 4 3.6 
Unspecified 25 22.5 
Total 111 100.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Descriptive Statistics 
 N Range Minimum Maximum Mean Std. Deviation Variance 
Opinions on Case Study 1 99 3 1 4 2.26 .921 .849 
Opinions on Case Study 2 96 3 1 4 2.17 .925 .856 
Opinions on Case Study 3 88 3 1 4 2.30 .937 .877 
Opinions on Case Study 4 86 3 1 4 2.57 .848 .719 
Table 4 descriptive statistics of participant’s opinions on each case study, where 1 = agree, 2 = neither agree nor disagree, 3 = disagree and 4 = not sure 
Table 3 participant’s opinions on each case study 
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Appendix D – Cross-Tabulation/Chi-Square Tests: 
(N.B. Results shown below grouped together ‘strongly agree’ with ‘agree’ responses and ‘strongly 
disagree’ with ‘disagree’ responses. Results shown not including ‘unspecified’, ‘neither agree nor 
disagree’, and ‘not sure’ responses. Results highlighted in yellow are statistically significant but may not 
be valid, results highlighted in green are statistically significant and valid.) 
Participant Factors: 
Case 1: 
 
 
 
 
 
 
 
 
Pearson Chi-Square Tests (Case Study 1) 
 Religion Practicing Religion 
Religion influenced 
Opinions? 
Opinions on Case Study 1 Chi-square 9.130 17.904 31.937 
df 1 1 1 
Sig. .003*,b .000*,b .000* 
Results are based on nonempty rows and columns in each innermost subtable. 
*. The Chi-square statistic is significant at the .05 level. 
Pearson Chi-Square Tests (Case Study 1) 
 Gender Age Ethnicity Post Code 
Opinions on Case Study 1 Chi-square 3.630 .256 .032 .436 
df 1 1 1 1 
Sig. .057 .613 .859 .509 
Results are based on nonempty rows and columns in each innermost subtable. 
Table 5 Pearson Chi-Square tests for Case Study 1. Tests include the link between participant’s opinions on the case study vs their 
demographics, such as gender, age, ethnicity and post code. 
Table 6 Pearson Chi-Square tests for Case Study 1. Tests include the link between participant’s opinions on the case study vs their religion, 
whether they practice their religion and whether they believe their religion influenced their opinions.  
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Case 2: 
 
 
 
 
 
 
 
Pearson Chi-Square Tests (Case Study 1) 
 Experience with Terminal Illness? 
Opinions on Case Study 1 Chi-square 1.514 
df 2 
Sig. .469 
Results are based on nonempty rows and columns in each innermost subtable. 
Pearson Chi-Square Tests (Case Study 2) 
 Gender Age Ethnicity Post Code 
Opinions on Case Study 2 Chi-square 3.245 .084 .454 1.457 
df 1 1 1 1 
Sig. .072 .772 .501 .227 
Results are based on nonempty rows and columns in each innermost subtable. 
 
Pearson Chi-Square Tests (Case Study 2) 
 Religion Practicing Religion 
Religion influenced 
Opinions? 
Opinions on Case Study 2 Chi-square 11.148 21.678 28.215 
df 1 1 1 
Sig. .001*,b .000*,b .000* 
Results are based on nonempty rows and columns in each innermost subtable. 
*. The Chi-square statistic is significant at the .05 level. 
b. More than 20% of cells in this subtable have expected cell counts less than 5. Chi-square results may be invalid. 
Table 7 Pearson Chi-Square tests for Case Study 1. Tests include the link between participant’s opinions on the case study vs their experience 
with terminal illness.  
Table 8 Pearson Chi-Square tests for Case Study 2. Tests include the link between participant’s opinions on the case study vs their demographics, 
such as gender, age, ethnicity and post code. 
Table 9 Pearson Chi-Square tests for Case Study 2. Tests include the link between participant’s opinions on the case study vs their religion, 
whether they practice their religion and whether they believe their religion influenced their opinions. 
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Case 3: 
 
 
 
 
Pearson Chi-Square Tests (Case Study 3) 
 Gender Age Ethnicity Post Code 
Opinions on Case Study 3 Chi-square 2.520 .187 .591 .001 
df 1 1 1 1 
Sig. .112 .665 .442 .980 
Results are based on nonempty rows and columns in each innermost subtable. 
Pearson Chi-Square Tests (Case Study 3) 
 Religion Practicing Religion 
Religion influenced 
Opinions? 
Opinions on Case Study 3 Chi-square 9.668 20.138 16.689 
df 1 1 1 
Sig. .002*,b .000*,b .000*,b 
Results are based on nonempty rows and columns in each innermost subtable. 
*. The Chi-square statistic is significant at the .05 level. 
b. More than 20% of cells in this subtable have expected cell counts less than 5. Chi-square results may be invalid. 
 
Pearson Chi-Square Tests (Case Study 2) 
 Experience with Terminal Illness 
Opinions on Case Study 2 Chi-square 1.963 
df 2 
Sig. .375 
            
 
Table 11 Pearson Chi-Square tests for Case Study 3. Tests include the link between participant’s opinions on the case study vs their 
demographics, such as gender, age, ethnicity and post code. 
Table 12 Pearson Chi-Square tests for Case Study 3. Tests include the link between participant’s opinions on the case study vs their religion, whether 
they practice their religion and whether they believe their religion influenced their opinions. 
Table 10 Pearson Chi-Square tests for Case Study 2. Tests include the link between participant’s opinions on the case study vs their experience with 
terminal illness.  
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Case 4: 
Pearson Chi-Square Tests (Case Study 3) 
 
Experience with 
Terminal Illness? 
Opinions on Case Study 3 Chi-square 5.226 
df 2 
Sig. .073 
Results are based on nonempty rows and columns in each innermost subtable. 
Pearson Chi-Square Tests (Case Study 4) 
 Gender Age Ethnicity Post Code 
Opinions on Case Study 4 Chi-square .101 .405 .147 .005 
df 1 1 1 1 
Sig. .751a .524a .701 .946 
Results are based on nonempty rows and columns in each innermost subtable. 
a. More than 20% of cells in this subtable have expected cell counts less than 5. Chi-square results may be invalid. 
 
Pearson Chi-Square Tests (Case Study 4) 
 Religion Practicing Religion 
Religion influenced 
Opinions? 
Opinions on Case Study 4 Chi-square 15.220 11.733 12.599 
df 1 1 1 
Sig. .000*,b .001*,b .000*,b 
Results are based on nonempty rows and columns in each innermost subtable. 
*. The Chi-square statistic is significant at the .05 level. 
b. More than 20% of cells in this subtable have expected cell counts less than 5. Chi-square results may be invalid. 
Table 13 Pearson Chi-Square tests for Case Study 3. Tests include the link between participant’s opinions on the case study vs their experience 
with terminal illness.  
Table 15 Pearson Chi-Square tests for Case Study 4. Tests include the link between participant’s opinions on the case study vs their religion, 
whether they practice their religion and whether they believe their religion influenced their opinions. 
Table 14 Pearson Chi-Square tests for Case Study 4. Tests include the link between participant’s opinions on the case study vs their 
demographics, such as gender, age, ethnicity and post code. 
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Pearson Chi-Square Tests (Case Study 4) 
 
Experience with Terminal 
Illness 
Opinions on Case Study 4 Chi-square 5.570 
df 2 
Sig. .062a 
Results are based on nonempty rows and columns in each innermost subtable. 
a. More than 20% of cells in this subtable have expected cell counts less than 5. Chi-square results may 
be invalid. 
Pearson Chi-Square Tests 
 
Opinions on 
Dispensing CS1 
Opinions on 
Dispensing CS2 
Opinions on 
Dispensing CS3 
Opinions on 
Dispensing CS4 
Believe they have been 
taught aspects of 
accompanied suicide on 
their MPharm course? 
Chi-square .038 .091 1.149 .108 
df 1 1 1 1 
Sig. .845 .763 .284 .743a 
Results are based on nonempty rows and columns in each innermost subtable. 
a. More than 20% of cells in this subtable have expected cell counts less than 5. Chi-square results may be invalid. 
Table 16 Pearson Chi-Square tests for Case Study 4. Tests include the link between participant’s opinions on the 
case study vs their experience with terminal illness.  
Table 17 Pearson Chi-Square tests against participants’ opinions on dispensing lethal medication for accompanied suicide 
vs whether they believe they have been taught aspects of accompanied suicide during their MPharm course.  
